Project Grant HT94252310744
Award Date
8/1/23
Completion Date
7/31/27
Dollars Obligated
$2.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
The Defense Health Agency awarded a Project Grant titled "PROGESTIN THERAPY FOR ENDOMETRIAL CANCER" to the University of Utah in the amount of $470,919.00 under the Military Medical Research and Development program (CFDA 12.420). The grant, with a period of performance from August 1, 2023 to July 31, 2027, will fund research to investigate medical solutions for the battlefield, with a focus on transforming healthcare for Service Members and the American public through innovative and...
This Project Grant award of $1,539,469.00 from the Defense Health Agency was provided to the University of Utah under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "Molecular Crosstalk Between Estrogens and Progestogens in Endometrial Cancer." The award will fund this biomedical research project from September 1, 2023 to August 31, 2026. The University of Utah has an extensive track record of collaborating with government agencies on...
The University of Iowa was awarded a $1,529,022 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research from February 2021 to February 2024 to investigate SUMO inhibition and its ability to repress mammary oncogenesis through the ETV1 protein. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
This federal Project Grant award, totaling $3,560,880, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the public. The primary awardee, the University of Kansas Medical Center Research Institute, Inc. (KUMCRI), will conduct sophisticated scientific investigations to address various medical...
The University of Iowa received a $816,178 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETED THERAPY FOR MPNST METASTASIS," will support research activities at the University of Iowa from June 1, 2024 to May 31, 2027. The research aims to develop innovative treatments for metastatic malignant peripheral nerve sheath tumors, a rare and aggressive type of cancer. This federal grant...
The Defense Health Agency awarded a $312,000 Project Grant to the Regents of the University of Michigan to support research determining a role for PP2A in the development and treatment of endometriosis. The grant period runs from January 15, 2023 to January 14, 2025. The research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through...
This $1,529,953 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Miami to understand the genomic landscape of endometrial cancer in Black women. The project aims to advance scientific understanding of this disease and its impact on a population that is disproportionately affected. The research will be conducted by the University of Miami's Office of Research Administration -...
The University of Iowa received a $155,500 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant funding will support a targeted approach to inhibiting the NRF2 pathway in neuroendocrine cancers. This award, with a performance period from November 1, 2024 to October 31, 2026, is part of the program's efforts to transform healthcare for military service members and the general public...
The U.S. Defense Health Agency awarded a $1,449,000 Project Grant to Duke University to conduct research aimed at "Identifying Essential Molecular Mechanisms for Advanced Prostate Cancer Growth by a New Chemical Compound." This grant is funded under the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,759,708.00 to Iowa State University of Science and Technology to develop high-throughput, high-resolution in vitro models of prostate cancer bone marrow metastases. The award, effective from April 15, 2025 to April 14, 2028, supports advanced biomedical research focused on transforming healthcare for military service members and...